GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
46.52 +0.24  +0.52% NYSE Nov 26, 8:00PM BATS Real time Currency in USD

GlaxoSmithKline Cash from Operations (TTM):

8.445B for Sept. 30, 2014

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Cash from Operations (TTM) Chart

Export Data
Save Image

GlaxoSmithKline Historical Cash from Operations (TTM) Data

View and export this data going back to 1985. Start your Free Trial
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Sept. 30, 2014 8.445B
June 30, 2014 9.602B
March 31, 2014 10.89B
Dec. 31, 2013 11.30B
Sept. 30, 2013 10.85B
June 30, 2013 7.127B
March 31, 2013 7.279B
Dec. 31, 2012 6.932B
Sept. 30, 2012 7.295B
June 30, 2012 10.66B
March 31, 2012 10.03B
Dec. 31, 2011 10.02B
Sept. 30, 2011 8.838B
June 30, 2011 7.892B
March 31, 2011 8.769B
Dec. 31, 2010 10.50B
Sept. 30, 2010 11.35B
June 30, 2010 13.14B
March 31, 2010 13.05B
Dec. 31, 2009 12.24B
Sept. 30, 2009 12.79B
June 30, 2009 12.37B
March 31, 2009 12.14B
Dec. 31, 2008 13.21B
Sept. 30, 2008 12.25B
   
June 30, 2008 12.78B
March 31, 2008 12.87B
Dec. 31, 2007 12.34B
Sept. 30, 2007 12.33B
June 30, 2007 8.539B
March 31, 2007 7.929B
Dec. 31, 2006 8.020B
Sept. 30, 2006 7.843B
June 30, 2006 10.92B
March 31, 2006 11.52B
Dec. 31, 2005 10.83B
Sept. 30, 2005 10.10B
June 30, 2005 10.20B
March 31, 2005 9.703B
Dec. 31, 2004 9.055B
Sept. 30, 2004 8.868B
June 30, 2004 8.614B
March 31, 2004 7.995B
Dec. 31, 2003 7.927B
Sept. 30, 2003 8.051B
June 30, 2003 7.428B
March 31, 2003 8.183B
Dec. 31, 2002 8.085B
Sept. 30, 2002 8.463B
June 30, 2002 7.875B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Operations

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.

Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More

Get data for
Advertisement

GSK Cash from Operations (TTM) Benchmarks

Companies
AstraZeneca 7.694B
Johnson & Johnson 18.24B
Novartis 13.14B

GSK Cash from Operations (TTM) Range, Past 5 Years

Minimum 6.932B Dec 2012
Maximum 13.14B Jun 2010
Average 9.810B

GSK Cash from Operations (TTM) Excel Add-In Codes

  • Metric Code: cash_operations_ttm
  • Latest data point: =YCP("GSK", "cash_operations_ttm")
  • Last 5 data points: =YCS("GSK", "cash_operations_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.